Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
International Journal of Cancer|June 27, 2015
L1CAM in human cancerPeter Altevogt, Kai Doberstein, Mina FogelCellular and Molecular Life Sciences : CMLS|March 19, 2010
L1CAM malfunction in the nervous system and human carcinomasMichael K E Schäfer, Peter AltevogtThe Journal of Biological Chemistry|August 11, 2011
Contractile forces contribute to increased glycosylphosphatidylinositol-anchored receptor CD24-facilitated cancer cell invasionClaudia Tanja Mierke, Niko Bretz, Peter AltevogtMethods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Exosomes as a potential tool for a specific delivery of functional moleculesIrina Nazarenko, Anne-Kathleen Rupp, Peter AltevogtBMC Cancer|March 29, 2011
Interaction and uptake of exosomes by ovarian cancer cellsCristina Escrevente, Sascha Keller, Peter Altevogt, et al.International Journal of Cancer|August 14, 2020
Novel insights into the function of CD24: A driving force in cancerPeter Altevogt, Marei Sammar, Laura Hüser, et al.Journal of Cell Science|January 5, 2006
CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cellsHeidi Schabath, Steffen Runz, Safwan Joumaa, et al.Neuroscience Letters|October 19, 2007
Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosisCatarina Gomes, Sascha Keller, Peter Altevogt, et al.Journal of Immunological Methods|May 14, 2015
A novel method for measuring cellular antibody uptake using imaging flow cytometry reveals distinct uptake rates for two different monoclonal antibodies targeting L1John Hazin, Gerhard Moldenhauer, Peter Altevogt, et al.Expert Review of Molecular Diagnostics|July 1, 2004
L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomasMina Fogel, Monica Huszar, Peter Altevogt, et al.Pageof 16